1. Home
  2. ELEV vs CREX Comparison

ELEV vs CREX Comparison

Compare ELEV & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • CREX
  • Stock Information
  • Founded
  • ELEV 2019
  • CREX N/A
  • Country
  • ELEV United States
  • CREX United States
  • Employees
  • ELEV N/A
  • CREX N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • CREX EDP Services
  • Sector
  • ELEV Health Care
  • CREX Technology
  • Exchange
  • ELEV Nasdaq
  • CREX Nasdaq
  • Market Cap
  • ELEV 37.6M
  • CREX 44.8M
  • IPO Year
  • ELEV 2021
  • CREX N/A
  • Fundamental
  • Price
  • ELEV $0.58
  • CREX $2.95
  • Analyst Decision
  • ELEV Strong Buy
  • CREX Strong Buy
  • Analyst Count
  • ELEV 5
  • CREX 2
  • Target Price
  • ELEV $7.20
  • CREX $8.00
  • AVG Volume (30 Days)
  • ELEV 860.8K
  • CREX 65.6K
  • Earning Date
  • ELEV 11-06-2024
  • CREX 11-13-2024
  • Dividend Yield
  • ELEV N/A
  • CREX N/A
  • EPS Growth
  • ELEV N/A
  • CREX N/A
  • EPS
  • ELEV N/A
  • CREX 0.07
  • Revenue
  • ELEV N/A
  • CREX $54,300,000.00
  • Revenue This Year
  • ELEV N/A
  • CREX $22.92
  • Revenue Next Year
  • ELEV N/A
  • CREX $18.39
  • P/E Ratio
  • ELEV N/A
  • CREX $41.26
  • Revenue Growth
  • ELEV N/A
  • CREX 31.80
  • 52 Week Low
  • ELEV $0.44
  • CREX $2.09
  • 52 Week High
  • ELEV $5.83
  • CREX $5.20
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 43.94
  • CREX 42.78
  • Support Level
  • ELEV $0.60
  • CREX $2.76
  • Resistance Level
  • ELEV $0.70
  • CREX $3.10
  • Average True Range (ATR)
  • ELEV 0.08
  • CREX 0.23
  • MACD
  • ELEV -0.01
  • CREX 0.04
  • Stochastic Oscillator
  • ELEV 7.67
  • CREX 66.13

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: